Vaccine Ingredients: Mrc-5 Cell Line Presence

MRC-5 (Medical Research Council cell strain 5) is a cell culture line composed of fibroblasts derived from the lung tissue of a 14-week-old aborted fetus. It is one of the two main human cell strains, along with WI-38, that have been used in vaccine development since the 1960s. Human fetal cells are valuable in vaccine research because they support the growth of many human viruses and are sterile. While some people have ethical concerns about the use of fetal cells in vaccines, religious leaders from major religions, including Catholicism, have deemed it morally acceptable. This paragraph will discuss the presence of MRC-5 in vaccines and address the concerns surrounding its use.

Explore related products

The Vaccine-Friendly Plan: Dr. Paul's Safe and Effective Approach to Immunity and Health-from Pregnancy Through Your Child's Teen Years

$11.29 $22

Miller's Review of Critical Vaccine Studies: 400 Important Scientific Papers Summarized for Parents and Researchers

$20.41 $21.95

MRC-5 is composed of cells from an aborted fetus

MRC-5 (Medical Research Council cell strain 5) is a cell culture line composed of fibroblasts. It was originally developed from the lung tissue of a 14-week-old aborted white male foetus in 1966. The cell line was isolated by J.P. Jacobs and his colleagues and is known to reach senescence in around 45 population doublings.

The use of human fetal cells in vaccine development often raises ethical concerns and questions about the morality and religious implications of such practices. However, human fetal cells are valuable in vaccine research because they support the growth of many human viruses and are sterile. The use of fetal cells also reduces the risk of contamination by unknown animal viruses, which was a concern in the past when vaccines were grown in animal cells.

MRC-5 cells are currently used to produce several vaccines, including those for hepatitis A, varicella, polio, chickenpox, and shingles. During the COVID-19 pandemic, there were misconceptions that MRC-5 was an ingredient in the Oxford–AstraZeneca COVID-19 vaccine. However, David Matthews, a co-author of the study in question, clarified that MRC-5 was only used for testing purposes to understand how the vaccine behaves inside a genetically normal human cell. The Oxford–AstraZeneca vaccine was manufactured using the HEK 293 fetal cell line, which came from the kidney cells of an aborted or spontaneously miscarried female fetus. These cells are filtered out of the final vaccine product.

While some people may have concerns or objections to the use of fetal cells in vaccine development, it is important to understand the history and ongoing impact of such practices. The use of fetal cells in vaccines has a long history, dating back to the 1950s and 1960s, and has contributed to the development of vaccines against various diseases.

Fetal cells are valuable in vaccine research

Fetal cells have been used in vaccine research and development for decades, playing a crucial role in creating vaccines for several diseases. The use of these cells, however, has recently come under ethical scrutiny as the public has become more aware of their presence in vaccines.

The WI-38 cell line, derived from the lung tissue of a female fetus in the early 1960s, has been used to develop vaccines against polio, rubella, and rabies. Another cell line, MRC-5, was developed from the lung tissue of a 14-week-old aborted male fetus in 1966. Vaccines that have been produced using MRC-5 cells include those for hepatitis A, varicella (chickenpox), shingles, and rabies.

Additionally, fetal cells have rapid reproduction rates, allowing researchers to create an immortal tissue line. This immortality is highly advantageous for vaccine research and development, as it enables the mass production of fetal tissue cells, facilitating the concurrent research of numerous products. Fetal cells also retain normal cellular physiology, making them valuable for understanding and studying viral behaviours, such as virus replication and amplification. For example, MRC-5 cells have been used to study the replication of the poliovirus, the mechanisms of SARS-CoV amplification, and the generation of the herpes simplex virus.

While the use of fetal cells in vaccine research and development has raised ethical concerns, it is important to note that these cells have been instrumental in creating life-saving vaccines. The ongoing search for ethical alternatives has led to the use of eggs and other animal by-products in vaccine production, demonstrating a commitment to addressing these concerns.

Vaccines do not contain fetal cells or DNA

Claims that vaccines contain aborted foetal tissue, DNA, and cells are false. While some vaccines were indeed developed using human cell lines, there are no fetal cells, tissue, or DNA in the finished product. The DNA from these fetal cells is no longer recognisable as human DNA because the process of growing the viruses kills the cells and the vaccine virus is purified, which breaks down the cellular DNA.

The confusion surrounding this topic may be due to the historical use of fetal cells in vaccine development. In the 1950s and 1960s, researchers at the Wistar Institute of Anatomy and Biology, under the direction of Dr. Hayflick, Koprowski, and Plotkin, made a significant discovery. They realized that as long as viral vaccines were grown in animal cells, there was a risk of contamination by unknown viruses. This concern was further validated when it was discovered that the monkey kidney cells used in the Salk and Sabin polio vaccines were contaminated with Simian Virus-40 (SV40), a cancer-causing virus in monkeys.

Fetal cells offered a solution as they were much less likely to have been exposed to viruses. This led to the preparation of two cell lines, WI-38 and MRC-5, derived from elective abortions performed in Europe in the early 1960s. These cell lines were used to develop vaccines against diseases such as polio, rubella, rabies, hepatitis A, chickenpox, and shingles. However, it is important to emphasize that the vaccines themselves do not contain fetal cells or DNA.

The presence of fetal DNA fragments in vaccines produced using fetal cell lines is a complex issue. While some argue that vaccines contain human DNA fragments, the amount present is minimal and highly fragmented due to the nature of the vaccine production process. Additionally, the DNA is marginally modified from the original source, making it unrecognizable as human DNA.

It is worth noting that the use of fetal cells in vaccine development has raised ethical concerns, particularly among those opposed to abortion. While these concerns are valid, the use of fetal cells has undoubtedly improved and saved countless lives, as noted by Associate Professor Griffin. Additionally, religious authorities like the Vatican have considered these concerns, concluding that such vaccines could be used if no suitable alternatives are available.

Religious leaders have evaluated the use of fetal cells in vaccines

The use of fetal cells in vaccines has been a topic of discussion and debate among various groups, including religious leaders and communities. While some religious groups have not explicitly commented on the use of fetal cells in vaccines, there are concerns among certain religious individuals about whether the use of such cells is immoral or against their religious beliefs.

The use of fetal cells in vaccine development is not a new concept. Since the 1950s and 1960s, researchers have been utilizing fetal cells to create vaccines against various diseases. Fetal cells were first used when it was discovered that monkey kidney cells, which were previously used to grow polio vaccines, were contaminated with the SV40 virus, a cancer-causing virus in monkeys. It is important to note that the SV40 virus did not cause cancer in humans, but this discovery sparked concerns about potential contamination by unknown viruses in animal cells.

Fetal cells, specifically those derived from elective abortions, have been valuable in vaccine research for several reasons. These cells support the growth of many human viruses and are sterile. The two commonly known fetal cell lines are MRC-5 and WI-38, both established in the early 1960s. MRC-5, or Medical Research Council cell strain 5, was isolated from lung tissue of a 14-week-old aborted male fetus. This cell line has been used to produce vaccines for hepatitis A, varicella, polio, chickenpox, and shingles. On the other hand, the WI-38 cell line has been used to develop vaccines against rubella, rabies, and polio.

While some religious leaders and individuals have not explicitly condemned the use of fetal cells in vaccines, there are alternative vaccines recommended by certain groups. Ethicists, for example, have suggested the use of alternate vaccines if available and have encouraged speaking out against abortion by requesting that governments and vaccine manufacturers discontinue the use of cell lines linked to aborted fetuses.

Fetal cells have prevented millions of deaths

Fetal cells have been used to develop vaccines since the 1960s. The WI-38 cell strain, which originated from an aborted fetus in 1962, has been used to develop the rubella vaccine, which has prevented over 633,000 miscarriages in the US alone and countless more across the globe. It has also prevented tens of millions of clinical health issues in children, such as encephalitis, autism, deafness, and diabetes, which are linked to congenital rubella syndrome.

The use of fetal cells in vaccine development has led to huge advances in vaccine technology and has prevented many millions of deaths worldwide. The World Health Organization estimates that all immunizations now available avert about 2.5 million deaths among children every year. However, many more lives could be saved if vaccines were universally available.

Fetal cells are valuable in vaccine research because they support the growth of many human viruses and are sterile. They were first used when researchers found that primary monkey kidney cells, which were being used to develop the polio vaccine, were contaminated with the SV40 virus. Fetal cells were much less likely to have been exposed to viruses, making them a safer alternative.

The use of fetal cells in vaccine development has been a controversial topic, particularly for those who oppose abortion. However, it is important to note that there are no "aborted fetal cells" in vaccines. Rather, human cell lines derived from aborted fetuses are used to make some vaccines. The Catholic Church, for example, permits Roman Catholics in good faith to receive COVID-19 vaccines that use fetal cell lines in development or production.

Frequently asked questions